Delivering Surgical Solutions Globally
Corporate Development
SKsurgitech –
Focused Surgical Solutions
Backed by Experience
Founded in 2021, SKsurgitech is the specialized surgical equipment brand of SAIKANG Medical, dedicated to delivering integrated solutions for operating rooms and clinical environments.
- Advanced production facilities
- Independent R&D capabilities
- Strict quality control processes
Company history.
Today, it serves over 140 countries with strong R&D and manufacturing capabilities.
SAIKANG Medical, founded in 2002, is a global manufacturer of reliable medical equipment. It expanded from hospital beds to a full range of clinical and surgical solutions and was listed in 2016 (Stock Code: 870098).
2002
Founded
SAIKANG Medical was founded in Zhangjiagang, at a time when China’s medical equipment industry was still in its early stage of modernization. Against the backdrop of rapidly developing domestic healthcare reform, the company began with a clear mission: to provide reliable, practical medical equipment that could meet the growing needs of hospitals across China.
2006
First Breakthrough
SAIKANG secured its first domestic order, marking a strong start for long-term growth. This early success drove its first expansion and relocation, along with the establishment of pre-processing workshops and additional production lines, moving toward more specialized manufacturing.
- Secured First Domestic Order
- Production capacity was tripled, ISO, CE approval
- Expanded Capacity & Advanced Manufacturing
2010
Global Expansion Begins
SAIKANG initiated its international expansion by establishing its foreign trade business, taking its first step into global markets. Through its export efforts, the company began to showcase the strength of Chinese medical manufacturing and quality to overseas healthcare providers, earning growing recognition in international markets.
- Started international expansion
2013
Production Upgrade & Technology Recognition
The factory relocated to Changyinsha Modern Agriculture Demonstration Park, providing an upgraded production environment and improved capacity. In the same year, SAIKANG was recognized as a National High-Tech Enterprise, reflecting its growing strength in manufacturing and innovation.
- Relocation to Changyinsha improved production capacity and efficiency.
- SAIKANG was recognized as a National High-Tech Enterprise for its innovation strength.
2016
Entering Capital Market
SAIKANG was successfully listed on the National Equities Exchange and Quotations (NEEQ, Stock Code: 870098), marking a significant milestone in its development.
2018
Healthcare Diversification
SAIKANG established MINYUE and LAMDER, expanding into healthcare development supported by social welfare initiatives and diversified industry engagement.
- Healthcare Expansion
- Social Initiatives
2021
Integrated Expansion
Launched the Shazhou Jikang brand, initiating a “Medical Equipment–Pharmaceutical–Healthcare” integrated group layout. Established Chengdu subsidiary, followed by subsidiaries and offices in Guangzhou, Shanghai, Nanjing, and other cities nationwide.
- Integrated Healthcare Group Layout
- Nationwide Expansion Network
2021-2023
Social Responsibility
Dedicated to public welfare and social responsibility, contributing to earthquake and flood relief, global pandemic assistance, rural healthcare development, and educational support for children in mountainous areas.
2024
Worldwide Expansion
After the establishment of the U.S. branch, the Poland factory, and the showrooms in Portugal and Brazil, the Southeast Asia Thailand branch has been officially founded.
- Expansion across the United States, Europe, South America, and Southeast Asia.
2025
Awarded the China Industry-University-Research Cooperation Innovation Award. Subsidiaries in Saudi Arabia, India, and Indonesia are under preparation, further expanding the global footprint.
- Awarded the China Industry-University-Research Cooperation Innovation Award.
- Subsidiaries in Saudi Arabia, India, and Indonesia under preparation to strengthen global presence.